MedWatch

This is what the appeal trials will cost for Lundbeck

Lundbeck has decided to appeal the historical fine of DKK 700m (USD 124m) that the company has been handed by the EU Commission. That manoeuvre will run the company far less than the massive fine.

Foto: Colourbox

Trial costs for what is likely to be two separate appeal trials will be a costly affair for the Danish pharmaceutical company – the question is; how costly?

“I don’t know how much trial costs will run us. I have even consulted our external lawyer on the matter, and he doesn’t dare to venture a guess either. It also depends on how long it will run for, how many pleadings there will be, etc. I hope I can keep it below DKK 10m (USD 1.77m), but I don’t know” says Mette Carlstedt, legal director in Lundbeck, in an interview with Medwatch.

Allerede abonnent? Log ind.

Læs hele artiklen

Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

MedWatch job

Se flere jobs

Se flere jobs

Watch job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier